Gureeva T A, Kugaevskaia E V, Pozdnev V F, Prozorovskiĭ V N, Eliseeva Iu E, Solov'eva N I
Biomed Khim. 2007 Mar-Apr;53(2):172-80.
The new fluorogenic hexapeptide substrate CMC-Ala-Gly-Gly-Trp-Phe-Arg was used as substrate for endothelin-converting enzyme (ECE), angiotensin-converting enzyme (ACE) and neutral endopeptidase (NEP). The specific inhibitors lisinopril (ACE) and thiorphan (NEP) were used for identification of these enzyme activities,
新型荧光六肽底物CMC-丙氨酸-甘氨酸-甘氨酸-色氨酸-苯丙氨酸-精氨酸被用作内皮素转化酶(ECE)、血管紧张素转化酶(ACE)和中性内肽酶(NEP)的底物。特异性抑制剂赖诺普利(ACE)和硫磷酰胺(NEP)被用于鉴定这些酶活性。